Literature DB >> 10799892

Role of OCA-B in 3'-IgH enhancer function.

S Stevens1, J Ong, U Kim, L A Eckhardt, R G Roeder.   

Abstract

OCA-B (alternately called Bob1 and OBF-1) is a B cell-specific coactivator that interacts with the ubiquitously expressed Oct-1 and the B cell-restricted Oct-2 to activate transcription via the octamer site (5'-ATGCAAAT-3'). OCA-B-/- mice appear to undergo normal Ag-independent B cell maturation. However, Ag-dependent B cell differentiation, including germinal center formation, production of secondary Ig isotypes, and proliferation in response to surface Ig cross-linking, is greatly affected. We demonstrate that the observed reductions in expression of class-switched isotypes in OCA-B-/- mice may be due in part to deficiencies in the function of the 3'-IgH enhancer elements. Furthermore, we find that surface Ig cross-linking represses all the Ig enhancers and that this repression is absent in OCA-B-/- B cells. These results suggest an important role for OCA-B in Ig enhancer function in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799892     DOI: 10.4049/jimmunol.164.10.5306

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Identification of transcription coactivator OCA-B-dependent genes involved in antigen-dependent B cell differentiation by cDNA array analyses.

Authors:  Unkyu Kim; Rachael Siegel; Xiaodi Ren; Cary S Gunther; Terry Gaasterland; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

2.  TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.

Authors:  Ali I Kuraishy; Samuel W French; Mara Sherman; Marco Herling; Dan Jones; Randolph Wall; Michael A Teitell
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

3.  The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.

Authors:  J Hess; P J Nielsen; K D Fischer; H Bujard; T Wirth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Dynamic changes in binding of immunoglobulin heavy chain 3' regulatory region to protein factors during class switching.

Authors:  Sanjukta Chatterjee; Zhongliang Ju; Rabih Hassan; Sabrina A Volpi; Alexander V Emelyanov; Barbara K Birshtein
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

5.  Direct interactions of OCA-B and TFII-I regulate immunoglobulin heavy-chain gene transcription by facilitating enhancer-promoter communication.

Authors:  Xiaodi Ren; Rachael Siegel; Unkyu Kim; Robert G Roeder
Journal:  Mol Cell       Date:  2011-05-06       Impact factor: 17.970

Review 6.  The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  Courtney E W Sulentic; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2010-10-15       Impact factor: 4.849

7.  Mouse lymphoid cell line selected to have high immunoglobulin promoter activity.

Authors:  Dean Tantin; Phillip A Sharp
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  Discovery platform for inhibitors of IgH gene enhancer activity.

Authors:  Nathan G Dolloff
Journal:  Cancer Biol Ther       Date:  2018-11-27       Impact factor: 4.742

9.  Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma.

Authors:  Daniel L Di Bartolo; Elizabeth Hyjek; Shannon Keller; Ilaria Guasparri; Hongyu Deng; Ren Sun; Amy Chadburn; Daniel M Knowles; Ethel Cesarman
Journal:  J Virol       Date:  2009-02-18       Impact factor: 5.103

10.  In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.

Authors:  Yi Yan; Sung Sup Park; Siegfried Janz; Laurel A Eckhardt
Journal:  Genes Chromosomes Cancer       Date:  2007-10       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.